| ANRIL | bladder cancer | qPCR etc. | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 32231490 | 2020 |
| ANRIL | osteosarcoma | qPCR, Luciferase reporter assay, Western blot | L | ✔ | ✔ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | 30777616 | 2019 |
| ANRIL | laryngeal squamous cell cancer | RT-qPCR, Western blot, Dual luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31960744 | 2020 |
| ANRIL | acute myeloid leukemia | qRT-PCR, Dual-luciferase reporter assay, Western blot analysis | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31830533 | 2020 |
| ANRIL | hepatocellular carcinoma | qRT-PCR, Western Blot, Luciferase Activity Assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31679275 | 2019 |
| ANRIL | hepatocellular carcinoma | qRT-PCR, Western blotting, Luciferase reporter analysis, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31670868 | 2020 |
| ANRIL | laryngeal squamous cell cancer | Dual luciferase reporter assay, qRT-PCR, Western blotting | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31667207 | 2019 |
| ANRIL | ovarian cancer | qRT-PCR , Luciferase reporter assay , Western blot etc. | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 31189742 | 2019 |
| ANRIL | retinoblastoma | qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31184221 | 2019 |
| ANRIL | hepatocellular carcinoma | qRT-PCR , Luciferase reporter assay , Western blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31609763 | 2019 |
| ANRIL | breast cancer | qRT-PCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 31572679 | 2019 |
| ANRIL | gastric cancer | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | 30156609 | 2018 |
| ANRIL | glioblastoma | microarray, qPCR | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30038703 | 2018 |
| ANRIL | gastric cancer | qPCR, Western blot, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✘ | 30431129 | 2019 |
| ANRIL | retinoblastoma | qPCR, Western blot, Other | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 30355646 | 2018 |
| ANRIL | colorectal cancer | qPCR, Luciferase reporter assay, Other | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30279206 | 2018 |
| ANRIL | adult T cell leukemia | qPCR, Luciferase reporter assay, RIP, Other | H | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 30258009 | 2018 |
| ANRIL | hepatocellular carcinoma | qPCR, Western blot, Other | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 30249208 | 2018 |
| ANRIL | glioma | qPCR, Western blot, Luciferase reporter assay, Other | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 30197521 | 2018 |
| ANRIL | papillary thyroid cancer | qPCR, Western blot, etc. | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 30703346 | 2019 |
| ANRIL | esophageal cancer | qPCR, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 30610814 | 2018 |
| ANRIL | pancreatic cancer | Luciferase, etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 30604909 | 2019 |
| ANRIL | head and neck squamous cell carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 30555745 | 2018 |
| ANRIL | oral squamous cell carcinoma | RNA-seq, qPCR, Western blot | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31364119 | 2019 |
| ANRIL | gastric cancer | qPCR, Western blot | H | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | 31242038 | 2019 |
| ANRIL | Intraductal Papillary Mucinous Neoplasms of the Pancreas | qPCR, etc. | L | ✔ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 28874676 | 2017 |
| ANRIL | neurofibromatosis type 1 | microarray, qPCR etc. | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 22034633 | 2011 |
| ANRIL | medulloblastoma | qPCR, Luciferase reporter assay, Western blot. | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 28513871 | 2017 |
| ANRIL | pancreatic cancer | qPCR, Cell transfection, Western blot, Cell migration and invasion assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 28344092 | 2017 |
| ANRIL | oral squamous cancer | qPCR, Western blot, etc. | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 29176691 | 2017 |
| ANRIL | ovarian cancer | qPCR, Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 27095571 | 2016 |
| ANRIL | glioblastoma | qPCR etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 27306825 | 2016 |
| ANRIL | lung cancer | qPCR, RNAi, Western blot, Cell apoptosis assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 25964559 | 2015 |
| ANRIL | laryngeal squamous cell cancer | qPCR etc. | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 25257554 | 2014 |
| ANRIL | colon cancer | qPCR, RNAi, Western blot, ChIP, Luciferase reporter assay, Cell proliferation assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 23416462 | 2013 |
| ANRIL | acute myeloid leukemia | qPCR, RNAi etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 18185590 | 2008 |
| ANRIL | oral cancer | qPCR, Luciferase reporter assay, in vitro knockdown etc. | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 29635126 | 2018 |
| ANRIL | triple negative breast cancer | qPCR, Luciferase reporter assay, RIP. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 28961506 | 2017 |
| ANRIL | glioma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 29057547 | 2017 |
| ANRIL | renal cell carcinoma | qPCR, RNAi, Western blot, Cell migration and invasion assay, CCK-8 assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 28251886 | 2017 |
| ANRIL | lung adenocarcinoma | qPCR, Western blot etc. | H | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | 28402932 | 2017 |
| ANRIL | gallbladder cancer | qPCR, Western blot etc. | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 26812694 | 2016 |
| ANRIL | thyroid cancer | qPCR, RNAi, Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 27507052 | 2016 |
| ANRIL | bladder cancer | qPCR, RNAi, Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 26800519 | 2016 |
| ANRIL | bladder cancer | qPCR, Western blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 26449463 | 2015 |
| ANRIL | serous ovarian cancer | qPCR, RNAi, Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 25845387 | 2015 |
| ANRIL | esophageal squamous cell carcinoma | qPCR, RNAi, Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 24747824 | 2014 |
| ANRIL | acute lymphoblastic leukemia | MassARRAY assay etc. | L | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 21414664 | 2011 |
| ANRIL | prostate cancer | qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 20541999 | 2010 |
| ANRIL | glioma | qPCR etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 20386740 | 2010 |
| ANRIL | acute lymphoblastic leukemia | qPCR, RNAi etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 18185590 | 2008 |
| ANRIL | melanoma | qPCR etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 28653984 | 2017 |
| ANRIL | colorectal cancer | qPCR, RNAi etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 26708220 | 2016 |
| ANRIL | melanoma | qPCR, RNAi, Western blot, Cell migration assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 27461581 | 2016 |
| ANRIL | colorectal cancer | qPCR, RNAi, Western blot, Northern blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 27286457 | 2016 |
| ANRIL | melanoma | qPCR etc. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 20386740 | 2010 |
| ANRIL | nasopharyngeal cancer | RT-qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 29463902 | 2018 |
| ANRIL | prostate cancer | RT-PCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29278879 | 2018 |
| ANRIL | breast cancer | microarray, qPCR etc. | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 28248879 | 2017 |
| ANRIL | osteosarcoma | qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 29201225 | 2017 |
| ANRIL | breast cancer | qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 26835415 | 2016 |
| ANRIL | cervical cancer | qPCR, RNAi etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 26408699 | 2015 |
| ANRIL | osteosarcoma | qPCR, RNAi etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 26408699 | 2015 |
| ANRIL | cervical cancer | qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 22487937 | 2013 |
| ANRIL | breast cancer | qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 17440112 | 2007 |
| ANRIL | non small cell lung cancer | qPCR etc. | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 29504701 | 2018 |
| ANRIL | non small cell lung cancer | qPCR, RNAi etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 26408699 | 2015 |
| ANRIL | gastric cancer | qPCR, RNAi, Western blot, RIP etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 24810364 | 2014 |
| ANRIL | colorectal cancer | qPCR, RNAi etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 27314206 | 2016 |
| ANRIL | gastric cancer | qPCR, RNAi, Western blot, Luciferase reporter assay, Cell proliferation assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 27027260 | 2016 |
| ANRIL | hepatocellular carcinoma | microarray, qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 27894309 | 2016 |
| ANRIL | gastric cancer | qPCR, RNAi etc. | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 27121324 | 2016 |
| ANRIL | nasopharyngeal cancer | qPCR, RNAi, Luciferase reporter assay, MTT assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 28117929 | 2017 |
| ANRIL | nasopharyngeal cancer | qPCR, Luciferase reporter assays | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 28402230 | 2017 |
| ANRIL | cervical cancer | qPCR, Luciferase Reporter Assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 28550682 | 2017 |
| ANRIL | osteosarcoma | qRT-PCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 29520337 | 2018 |
| ANRIL | cervical cancer | qPCR, RNAi, Western blot, Cell proliferation assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 27899255 | 2017 |
| ANRIL | breast cancer | qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 26409453 | 2016 |
| ANRIL | nasopharyngeal cancer | qPCR, RNAi, Western blot, MTT assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 27557514 | 2016 |
| ANRIL | osteosarcoma | qPCR, RNAi, Western blot, ChIP, Luciferase reporter assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 27688736 | 2016 |
| ANRIL | non small cell lung cancer | qPCR, RNAi, Western blot, Luciferase reporter assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 27307748 | 2016 |
| ANRIL | non small cell lung cancer | qPCR, RNAi, Cell proliferation assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 25889788 | 2015 |
| ANRIL | non small cell lung cancer | qPCR, Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 25504755 | 2014 |
| ANRIL | hepatocellular carcinoma | qRT-PCR, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 29127494 | 2017 |
| ANRIL | hepatocellular carcinoma | qPCR, Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 29029488 | 2017 |
| ANRIL | hepatocellular carcinoma | qPCR, RNAi etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 26045820 | 2015 |
| ANRIL | hepatocellular carcinoma | qPCR, RNAi, Western blot, RIP etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 25966845 | 2015 |
| ANRIL | hepatocellular carcinoma | qPCR, RNAi, Western blot, RIP, ChIP, Flow cytometry assay, Cell proliferation assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 27391317 | 2015 |
| ANRIL | bladder cancer | qPCR, RNAi, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 29861427 | 2015 |
| ANRIL | Intracranial Aneurysms | RNA immunoprecipitation;Western blot;Luciferase reporter assay;RNA immunoprecipitation; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 34286462 | 2021 |
| ANRIL | Gastric Cancer | Western blot;Flow Cytometry assay;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 34267814 | 2021 |